EMEA (Europe, Middle East and Africa) Veterinary Therapeutics Market Report 2017

Table of Contents

EMEA (Europe, Middle East and Africa) Veterinary Therapeutics Market Report 2017
1 Veterinary Therapeutics Overview
1.1 Product Overview and Scope of Veterinary Therapeutics
1.2 Classification of Veterinary Therapeutics
1.2.1 EMEA Veterinary Therapeutics Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Veterinary Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Anti-inflammatory
1.2.4 Parasiticides
1.2.5 Other
1.3 EMEA Veterinary Therapeutics Market by Application/End Users
1.3.1 EMEA Veterinary Therapeutics Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Hospitals
1.3.3 Veterinary Clinics
1.3.4 Drug Stores
1.4 EMEA Veterinary Therapeutics Market by Region
1.4.1 EMEA Veterinary Therapeutics Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Veterinary Therapeutics (2012-2022)
1.5.1 EMEA Veterinary Therapeutics Sales and Growth Rate (2012-2022)
1.5.2 EMEA Veterinary Therapeutics Revenue and Growth Rate (2012-2022)

2 EMEA Veterinary Therapeutics Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Veterinary Therapeutics Market Competition by Players/Manufacturers
2.1.1 EMEA Veterinary Therapeutics Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Veterinary Therapeutics Revenue and Share by Players (2012-2017)
2.1.3 EMEA Veterinary Therapeutics Sale Price by Players (2012-2017)
2.2 EMEA Veterinary Therapeutics (Volume and Value) by Type/Product Category
2.2.1 EMEA Veterinary Therapeutics Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Veterinary Therapeutics Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Veterinary Therapeutics Sale Price by Type (2012-2017)
2.3 EMEA Veterinary Therapeutics (Volume) by Application
2.4 EMEA Veterinary Therapeutics (Volume and Value) by Region
2.4.1 EMEA Veterinary Therapeutics Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Veterinary Therapeutics Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Veterinary Therapeutics Sales Price by Region (2012-2017)

3 Europe Veterinary Therapeutics (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Veterinary Therapeutics Sales and Value (2012-2017)
3.1.1 Europe Veterinary Therapeutics Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Veterinary Therapeutics Revenue and Growth Rate (2012-2017)
3.2 Europe Veterinary Therapeutics Sales and Market Share by Type
3.3 Europe Veterinary Therapeutics Sales and Market Share by Application
3.4 Europe Veterinary Therapeutics Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Veterinary Therapeutics Sales Volume by Countries (2012-2017)
3.4.2 Europe Veterinary Therapeutics Revenue by Countries (2012-2017)
3.4.3 Germany Veterinary Therapeutics Sales and Growth Rate (2012-2017)
3.4.4 France Veterinary Therapeutics Sales and Growth Rate (2012-2017)
3.4.5 UK Veterinary Therapeutics Sales and Growth Rate (2012-2017)
3.4.6 Russia Veterinary Therapeutics Sales and Growth Rate (2012-2017)
3.4.7 Italy Veterinary Therapeutics Sales and Growth Rate (2012-2017)
3.4.8 Benelux Veterinary Therapeutics Sales and Growth Rate (2012-2017)

4 Middle East Veterinary Therapeutics (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Veterinary Therapeutics Sales and Value (2012-2017)
4.1.1 Middle East Veterinary Therapeutics Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Veterinary Therapeutics Revenue and Growth Rate (2012-2017)
4.2 Middle East Veterinary Therapeutics Sales and Market Share by Type
4.3 Middle East Veterinary Therapeutics Sales and Market Share by Application
4.4 Middle East Veterinary Therapeutics Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Veterinary Therapeutics Sales Volume by Countries (2012-2017)
4.4.2 Middle East Veterinary Therapeutics Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Veterinary Therapeutics Sales and Growth Rate (2012-2017)
4.4.4 Israel Veterinary Therapeutics Sales and Growth Rate (2012-2017)
4.4.5 UAE Veterinary Therapeutics Sales and Growth Rate (2012-2017)
4.4.6 Iran Veterinary Therapeutics Sales and Growth Rate (2012-2017)

5 Africa Veterinary Therapeutics (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Veterinary Therapeutics Sales and Value (2012-2017)
5.1.1 Africa Veterinary Therapeutics Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Veterinary Therapeutics Revenue and Growth Rate (2012-2017)
5.2 Africa Veterinary Therapeutics Sales and Market Share by Type
5.3 Africa Veterinary Therapeutics Sales and Market Share by Application
5.4 Africa Veterinary Therapeutics Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Veterinary Therapeutics Sales Volume by Countries (2012-2017)
5.4.2 Africa Veterinary Therapeutics Revenue by Countries (2012-2017)
5.4.3 South Africa Veterinary Therapeutics Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Veterinary Therapeutics Sales and Growth Rate (2012-2017)
5.4.5 Egypt Veterinary Therapeutics Sales and Growth Rate (2012-2017)
5.4.6 Algeria Veterinary Therapeutics Sales and Growth Rate (2012-2017)

6 EMEA Veterinary Therapeutics Manufacturers/Players Profiles and Sales Data
6.1 Bayer AG
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Veterinary Therapeutics Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Bayer AG Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Boehringer Ingelheim GmbH
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Veterinary Therapeutics Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Boehringer Ingelheim GmbH Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Ceva Sante Animale
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Veterinary Therapeutics Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Ceva Sante Animale Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Dechra Pharmaceuticals PLC
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Veterinary Therapeutics Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Dechra Pharmaceuticals PLC Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Eli Lilly and Company (Elanco Animal Health)
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Veterinary Therapeutics Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Merck Animal Health
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Veterinary Therapeutics Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Merck Animal Health Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Sanofi (Merial Animal Health)
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Veterinary Therapeutics Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Sanofi (Merial Animal Health) Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Virbac
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Veterinary Therapeutics Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Virbac Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Vetoquinol S.A.
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Veterinary Therapeutics Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Vetoquinol S.A. Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Zoetis, Inc.
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Veterinary Therapeutics Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Zoetis, Inc. Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Veterinary Therapeutics Manufacturing Cost Analysis
7.1 Veterinary Therapeutics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Veterinary Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Veterinary Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Veterinary Therapeutics Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Veterinary Therapeutics Market Forecast (2017-2022)
11.1 EMEA Veterinary Therapeutics Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Veterinary Therapeutics Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Veterinary Therapeutics Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Veterinary Therapeutics Price and Trend Forecast (2017-2022)
11.2 EMEA Veterinary Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Veterinary Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Veterinary Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Veterinary Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Veterinary Therapeutics Sales Forecast by Type (2017-2022)
11.7 EMEA Veterinary Therapeutics Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Veterinary Therapeutics
Figure EMEA Veterinary Therapeutics Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Veterinary Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
Figure Anti-inflammatory Product Picture
Figure Parasiticides Product Picture
Figure Other Product Picture
Figure EMEA Veterinary Therapeutics Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Veterinary Therapeutics by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Veterinary Clinics Examples
Table Key Downstream Customer in Veterinary Clinics
Figure Drug Stores Examples
Table Key Downstream Customer in Drug Stores
Figure EMEA Veterinary Therapeutics Market Size (Million USD) by Region (2012-2022)
Figure Europe Veterinary Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Veterinary Therapeutics Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Veterinary Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Veterinary Therapeutics Revenue (Million USD) Status and Forecast by Countries
Figure Africa Veterinary Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Veterinary Therapeutics Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Veterinary Therapeutics Sales Volume and Growth Rate (2012-2022)
Figure EMEA Veterinary Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Veterinary Therapeutics Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Veterinary Therapeutics Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Veterinary Therapeutics Sales Share by Players (2012-2017)
Figure 2016 Veterinary Therapeutics Sales Share by Players
Figure 2017 Veterinary Therapeutics Sales Share by Players
Figure EMEA Veterinary Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Veterinary Therapeutics Revenue (Million USD) by Players (2012-2017)
Table EMEA Veterinary Therapeutics Revenue Share by Players (2012-2017)
Table 2016 EMEA Veterinary Therapeutics Revenue Share by Players
Table 2017 EMEA Veterinary Therapeutics Revenue Share by Players
Table EMEA Veterinary Therapeutics Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Veterinary Therapeutics Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Veterinary Therapeutics Sales Share by Type (2012-2017)
Figure Sales Market Share of Veterinary Therapeutics by Type (2012-2017)
Figure EMEA Veterinary Therapeutics Sales Market Share by Type (2012-2017)
Table EMEA Veterinary Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Veterinary Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Veterinary Therapeutics by Type in 2016
Table EMEA Veterinary Therapeutics Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Veterinary Therapeutics Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Veterinary Therapeutics Sales Share by Application (2012-2017)
Figure Sales Market Share of Veterinary Therapeutics by Application (2012-2017)
Figure EMEA Veterinary Therapeutics Sales Market Share by Application in 2016
Table EMEA Veterinary Therapeutics Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Veterinary Therapeutics Sales Share by Region (2012-2017)
Figure Sales Market Share of Veterinary Therapeutics by Region (2012-2017)
Figure EMEA Veterinary Therapeutics Sales Market Share in 2016
Table EMEA Veterinary Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Veterinary Therapeutics Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Veterinary Therapeutics by Region (2012-2017)
Figure EMEA Veterinary Therapeutics Revenue Market Share Regions in 2016
Table EMEA Veterinary Therapeutics Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Veterinary Therapeutics Revenue and Growth Rate (2012-2017)
Table Europe Veterinary Therapeutics Sales (K Units) by Type (2012-2017)
Table Europe Veterinary Therapeutics Market Share by Type (2012-2017)
Figure Europe Veterinary Therapeutics Market Share by Type in 2016
Table Europe Veterinary Therapeutics Sales (K Units) by Application (2012-2017)
Table Europe Veterinary Therapeutics Market Share by Application (2012-2017)
Figure Europe Veterinary Therapeutics Market Share by Application in 2016
Table Europe Veterinary Therapeutics Sales (K Units) by Countries (2012-2017)
Table Europe Veterinary Therapeutics Sales Market Share by Countries (2012-2017)
Figure Europe Veterinary Therapeutics Sales Market Share by Countries (2012-2017)
Figure Europe Veterinary Therapeutics Sales Market Share by Countries in 2016
Table Europe Veterinary Therapeutics Revenue (Million USD) by Countries (2012-2017)
Table Europe Veterinary Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Europe Veterinary Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Europe Veterinary Therapeutics Revenue Market Share by Countries in 2016
Figure Germany Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure France Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure UK Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Veterinary Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Veterinary Therapeutics Sales (K Units) by Type (2012-2017)
Table Middle East Veterinary Therapeutics Market Share by Type (2012-2017)
Figure Middle East Veterinary Therapeutics Market Share by Type (2012-2017)
Table Middle East Veterinary Therapeutics Sales (K Units) by Applications (2012-2017)
Table Middle East Veterinary Therapeutics Market Share by Applications (2012-2017)
Figure Middle East Veterinary Therapeutics Sales Market Share by Application in 2016
Table Middle East Veterinary Therapeutics Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Veterinary Therapeutics Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Veterinary Therapeutics Sales Volume Market Share by Countries in 2016
Table Middle East Veterinary Therapeutics Revenue (Million USD) by Countries (2012-2017)
Table Middle East Veterinary Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Middle East Veterinary Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Middle East Veterinary Therapeutics Revenue Market Share by Countries in 2016
Figure Saudi Arabia Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Veterinary Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Veterinary Therapeutics Sales (K Units) by Type (2012-2017)
Table Africa Veterinary Therapeutics Sales Market Share by Type (2012-2017)
Figure Africa Veterinary Therapeutics Sales Market Share by Type (2012-2017)
Figure Africa Veterinary Therapeutics Sales Market Share by Type in 2016
Table Africa Veterinary Therapeutics Sales (K Units) by Application (2012-2017)
Table Africa Veterinary Therapeutics Sales Market Share by Application (2012-2017)
Figure Africa Veterinary Therapeutics Sales Market Share by Application (2012-2017)
Table Africa Veterinary Therapeutics Sales Volume (K Units) by Countries (2012-2017)
Table Africa Veterinary Therapeutics Sales Market Share by Countries (2012-2017)
Figure Africa Veterinary Therapeutics Sales Market Share by Countries (2012-2017)
Figure Africa Veterinary Therapeutics Sales Market Share by Countries in 2016
Table Africa Veterinary Therapeutics Revenue (Million USD) by Countries (2012-2017)
Table Africa Veterinary Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Africa Veterinary Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Africa Veterinary Therapeutics Revenue Market Share by Countries in 2016
Figure South Africa Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Table Bayer AG Veterinary Therapeutics Basic Information List
Table Bayer AG Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer AG Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer AG Veterinary Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Bayer AG Veterinary Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim GmbH Veterinary Therapeutics Basic Information List
Table Boehringer Ingelheim GmbH Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH Veterinary Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Boehringer Ingelheim GmbH Veterinary Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Ceva Sante Animale Veterinary Therapeutics Basic Information List
Table Ceva Sante Animale Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ceva Sante Animale Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Ceva Sante Animale Veterinary Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Ceva Sante Animale Veterinary Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Dechra Pharmaceuticals PLC Veterinary Therapeutics Basic Information List
Table Dechra Pharmaceuticals PLC Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dechra Pharmaceuticals PLC Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Dechra Pharmaceuticals PLC Veterinary Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Dechra Pharmaceuticals PLC Veterinary Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Basic Information List
Table Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Merck Animal Health Veterinary Therapeutics Basic Information List
Table Merck Animal Health Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Animal Health Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Animal Health Veterinary Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Merck Animal Health Veterinary Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Sanofi (Merial Animal Health) Veterinary Therapeutics Basic Information List
Table Sanofi (Merial Animal Health) Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi (Merial Animal Health) Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi (Merial Animal Health) Veterinary Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Sanofi (Merial Animal Health) Veterinary Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Virbac Veterinary Therapeutics Basic Information List
Table Virbac Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Virbac Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Virbac Veterinary Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Virbac Veterinary Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Vetoquinol S.A. Veterinary Therapeutics Basic Information List
Table Vetoquinol S.A. Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Vetoquinol S.A. Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Vetoquinol S.A. Veterinary Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Vetoquinol S.A. Veterinary Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Zoetis, Inc. Veterinary Therapeutics Basic Information List
Table Zoetis, Inc. Veterinary Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Zoetis, Inc. Veterinary Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Zoetis, Inc. Veterinary Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Zoetis, Inc. Veterinary Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Veterinary Therapeutics
Figure Manufacturing Process Analysis of Veterinary Therapeutics
Figure Veterinary Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Veterinary Therapeutics Major Manufacturers in 2016
Table Major Buyers of Veterinary Therapeutics
Table Distributors/Traders List
Figure EMEA Veterinary Therapeutics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Veterinary Therapeutics Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Veterinary Therapeutics Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Veterinary Therapeutics Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Veterinary Therapeutics Sales Market Share Forecast by Region (2017-2022)
Table EMEA Veterinary Therapeutics Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Veterinary Therapeutics Revenue Market Share Forecast by Region (2017-2022)
Table Europe Veterinary Therapeutics Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Veterinary Therapeutics Sales Market Share Forecast by Countries (2017-2022)
Table Europe Veterinary Therapeutics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Veterinary Therapeutics Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Veterinary Therapeutics Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Veterinary Therapeutics Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Veterinary Therapeutics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Veterinary Therapeutics Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Veterinary Therapeutics Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Veterinary Therapeutics Sales Market Share Forecast by Countries (2017-2022)
Table Africa Veterinary Therapeutics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Veterinary Therapeutics Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Veterinary Therapeutics Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Veterinary Therapeutics Sales Market Share Forecast by Type (2017-2022)
Table EMEA Veterinary Therapeutics Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Veterinary Therapeutics Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.